For biotech CEO Rachel Haurwitz, CRISPR is big business https://t.co/pgBj9wr1VV
— The Propell Group (@ThePropellGroup) June 25, 2016
#healthtech
For biotech CEO Rachel Haurwitz, CRISPR is big business https://t.co/pgBj9wr1VV
— The Propell Group (@ThePropellGroup) June 25, 2016
#healthtech